Inaktiver Wert

Optimer Pharmaceuticals, Inc. Aktie

Aktien

Schlusskurs Nasdaq Andere Börsenplätze
- ^USD	-

Optimer Pharmaceuticals, Inc. : Pre-Market Analysis: Inovio Pharmaceuticals Inc., Sequenom Inc., and Optimer Pharmaceuticals Inc.	04.10.13
Optimer Pharmaceuticals, Inc. : Today's Research: Inovio Pharmaceuticals Inc., Onyx Pharmaceuticals Inc., Sequenom Inc. and Optimer Pharmaceuticals Inc.	29.08.13
Optimer Pharmaceuticals, Inc. : Laboratory Permits, Pending FDA Approvals, Clinical Study Presentations, and Financial Results Release - Research Report on Illumina, Theravance, Acorda, Synta, and Optimer	12.08.13
Optimer Pharmaceuticals, Inc. : Ryan & Maniskas, LLP Announces Investigation of Optimer Pharmaceuticals, Inc.	01.08.13
Optimer Pharmaceuticals, Inc. : Optimer Reports Second Quarter 2013 Financial Results	01.08.13

Sektor

	% 1. Jan.	Kap.
CSL LIMITED	-4.24%	86.85 Mrd.
SAMSUNG BIOLOGICS CO.,LTD.	+2.76%	40.16 Mrd.
BIOGEN INC.	-16.16%	31.28 Mrd.
UCB	+57.86%	25.27 Mrd.
BIOMARIN PHARMACEUTICAL INC.	-15.37%	15.33 Mrd.
BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD.	-9.12%	11.96 Mrd.
CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD.	-42.56%	11.61 Mrd.
SWEDISH ORPHAN BIOVITRUM AB	+6.89%	8.83 Mrd.
INNOVENT BIOLOGICS, INC.	-10.53%	7.94 Mrd.